Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07756372
A Multicenter, Superiority Randomized Controlled Trial of Three Interventions for Patients With a Progressive Collapsing Foot DeformityCanadian Institutes of Health Research (CIHR)Not Yet RecruitingNot Applicable
NCT07756372Not Yet Recruiting
Not Applicable
A Multicenter, Superiority Randomized Controlled Trial of Three Interventions fo...Canadian Institutes of He...
NCT07754318
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)Medtronic CardiovascularNot Yet RecruitingNot Applicable
NCT07754318Not Yet Recruiting
Not Applicable
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)Medtronic Cardiovascular
NCT07754045
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese AdultsLumos PharmaNot Yet RecruitingPhase 2
NCT07754045Not Yet Recruiting
Phase 2
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutid...Lumos Pharma
NCT07755644
Minimally Invasive Non-Surgical Periodontal TreatmentAtaturk UniversityNot Yet RecruitingNot Applicable
NCT07755644Not Yet Recruiting
Not Applicable
Minimally Invasive Non-Surgical Periodontal TreatmentAtaturk University
NCT07754877
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter StudyPeking University Aerospace Center HospitalNot Yet RecruitingNot Applicable
NCT07754877Not Yet Recruiting
Not Applicable
Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combin...Peking University Aerospa...
NCT07755202
Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapsed/Refractory LeukemiaFlorian KuchenbauerNot Yet RecruitingPhase 2
NCT07755202Not Yet Recruiting
Phase 2
Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapse...Florian Kuchenbauer
NCT07756567
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for PsychosisNational Institute of Mental Health (NIMH)Not Yet RecruitingNot Applicable
NCT07756567Not Yet Recruiting
Not Applicable
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Cl...National Institute of Men...
NCT07754968
Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Without Atopic DermatitisUniversity of Roma La SapienzaRecruitingNot Applicable
NCT07754968Recruiting
Not Applicable
Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Withou...University of Roma La Sap...
NCT07754331
Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/DapagliflozinAstraZenecaNot Yet RecruitingPhase 1
NCT07754331Not Yet Recruiting
Phase 1
Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolera...AstraZeneca
NCT07753928
PENTAGON: MS-Related Disability Worsening and Thalamic Volume LossJung Diagnostics GmbHEnrolling By Invitation
NCT07753928Enrolling By Invitation
—
PENTAGON: MS-Related Disability Worsening and Thalamic Volume LossJung Diagnostics GmbH
NCT07756411
Selective, Micropulse and Pattern Laser Trabeculoplasty in Medically Treated Open-angle Glaucoma.University of UdineCompletedNot Applicable
NCT07756411Completed
Not Applicable
Selective, Micropulse and Pattern Laser Trabeculoplasty in Medically Treated Ope...University of Udine
NCT07754240
A Clinical Investigational Study of AnkuraTM II AAA, IE and AE Stent Graft System for Endovascular Treatment of Abdominal Aortic AneurysmLifetech Scientific (Shenzhen) Co., Ltd.Not Yet RecruitingNot Applicable
NCT07754240Not Yet Recruiting
Not Applicable
A Clinical Investigational Study of AnkuraTM II AAA, IE and AE Stent Graft Syste...Lifetech Scientific (Shen...
NCT07754890
Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma Phase I/II TrialPeking Union Medical College HospitalRecruitingPhase 1
NCT07754890Recruiting
Phase 1
Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma Phase I/II TrialPeking Union Medical Coll...
NCT07754734
STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter MethylationDongguan People's HospitalNot Yet RecruitingPhase 2
NCT07754734Not Yet Recruiting
Phase 2
STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With M...Dongguan People's Hospita...
NCT07756177Active Not Recruiting
—
Guangzhou Preterm and Term Birth Cohort StudySun Yat-sen University
NCT07755774
Psychological Treatment for Adolescents With Self-injury Within Intensive Mental Health Outpatient Services: Randomized Controlled Pilot TrialKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07755774Not Yet Recruiting
Not Applicable
Psychological Treatment for Adolescents With Self-injury Within Intensive Mental...Karolinska Institutet
NCT07755943
An Evaluation of Long-Term Supplement Use on Biological Age and Metabolic Health Markers - The BioAge TrialBiofortis Clinical Research, Inc.Recruiting
NCT07755943Recruiting
—
An Evaluation of Long-Term Supplement Use on Biological Age and Metabolic Health...Biofortis Clinical Resear...
NCT07754929
E-Mergir: A Digital Psychosexual Intervention for the Promotion of Mental and Sexual Health of Prostate Cancer SurvivorsUniversidade do PortoRecruitingNot Applicable
NCT07754929Recruiting
Not Applicable
E-Mergir: A Digital Psychosexual Intervention for the Promotion of Mental and Se...Universidade do Porto
NCT07754396
Effect of Tranexamic Acid on Bleeding After Bariatric SurgeryG.Gennimatas General HospitalCompleted
NCT07754396Completed
—
Effect of Tranexamic Acid on Bleeding After Bariatric SurgeryG.Gennimatas General Hosp...
NCT07754474
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or ObesityBoehringer IngelheimNot Yet RecruitingPhase 1
NCT07754474Not Yet Recruiting
Phase 1
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerate...Boehringer Ingelheim
Result Breakdown
Not yet recruiting12 (60%)
Recruiting4 (20%)
Completed2 (10%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 13 (15%)